MODERNA, INC.

MRNA
Real-time Estimate Quote. Real-time Estimate  - 01/20 12:28:10 pm
123.475USD -1.23%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for infectious, autoimmune and cardiovascular diseases. Turnover per type of income can be broken down as follows:
- Collaboration revenue (79.8%);
- Grant revenue (20.2%).
At the end of 2019, the group possessed a portfolio of 6 development candidates in clinical studies, with three in phase II and three in phase I.

Number of employees : 830 people.
Sales per Business
20182019
USD
(in Million)
%USD
(in Million)
%
Transformative Medicines 135.07100% 60.21100%
Sales per region
20182019
USD
(in Million)
%USD
(in Million)
%
United States 135.07100% 60.21100%
Managers
Name Title
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
Noubar B. Afeyan Chairman
David W. Meline Chief Financial Officer
Juan Andres Chief Technical Operations & Quality Officer
Tal Zaks Chief Medical Officer
Paul L. Sagan Independent Non-Executive Director
Robert S. Langer Independent Non-Executive Director
Stephen A. Berenson Independent Non-Executive Director
Francois Nader Independent Non-Executive Director
Shareholders
Name Equities %
Fidelity Management & Research Co. LLC 34,185,703 8.64%
Flagship Pioneering 30,871,524 7.80%
The Vanguard Group, Inc. 27,192,049 6.87%
Stéphane Bancel 23,350,056 5.90%
Robert Langer 11,509,357 2.91%
Thélème Partners LLP 7,652,978 1.93%
BlackRock Fund Advisors 7,253,490 1.83%
Baillie Gifford & Co. 7,225,636 1.83%
SSgA Funds Management, Inc. 6,583,927 1.66%
Geode Capital Management LLC 3,364,785 0.85%
Company contact information
200 Square Technology
MA 02139 Cambridge, Massachusetts


Phone : +1 617 714 6500
Fax : +1 617 583 1998
web site : https://www.modernatx.com
Markets and indexes
-
- Nasdaq Global Select Market
- Nasdaq 100 /
Stock Exchange Codes
- Reuters Code :  MRNA.O
Sector Biotechnology & Medical Research - NEC
1st jan.Capi. (M$)
MODERNA, INC.19.66%49 468
LONZA GROUP AG1.97%48 472
CELLTRION, INC.-12.95%38 667
IQVIA HOLDINGS INC.5.47%36 230
SEAGEN INC.7.75%34 149
HANGZHOU TIGERMED CONSULTING CO.,LTD-1.58%21 275
INCYTE CORPORATION4.12%20 577
ALNYLAM PHARMACEUTICALS, INC.29.58%19 566
PHARMARON BEIJING CO., LTD.4.15%15 255
CRISPR THERAPEUTICS AG29.51%14 657
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.9.55%13 873
BIO-TECHNE CORPORATION10.78%13 582
PPD, INC.5.04%12 568
QIAGEN N.V.2.48%12 316
ICON PUBLIC LIMITED COMPANY10.33%11 353
IONIS PHARMACEUTICALS, INC.7.94%8 533
PRA HEALTH SCIENCES, INC.5.97%8 527
ACADIA PHARMACEUTICALS INC.-0.17%8 485
SYNEOS HEALTH, INC.13.21%8 015
UNITED THERAPEUTICS CORPORATION13.06%7 626
GALAPAGOS NV8.92%6 950
Brand Portfolio
MODERNA THERAPEUTICS
MODERNA THERAPEUTICS
» More brands of Moderna, Inc.